Literature DB >> 28497349

SUV navigator enables rapid [18F]-FDG PET/CT image interpretation compared with 2D ROI and 3D VOI evaluations.

Atsutaka Okizaki1, Michihiro Nakayama2, Shunta Ishitoya2, Kaori Nakajima2, Masaaki Yamashina2, Tamio Aburano2, Koji Takahashi2.   

Abstract

PURPOSE: Positron emission tomography (PET) and the maximum standardized uptake value (SUVmax) is a useful technique for assessing malignant tumors. Measurements of SUVmax in multiple lesions per patient frequently require many time-consuming procedures. To address this issue, we designed a novel interface named SUV Navigator (SUVnavi), and the purpose of this study was to investigate its utility.
MATERIALS AND METHODS: We measured SUVmax in 661 lesions from 100 patients with malignant tumors. Diagnoses and SUVmax measurements were made with SUVnavi, 2D, and 3D measurements. SUV measurement accuracy in each method were also evaluated.
RESULTS: The average reduction in time with SUVnavi versus 2D was 53.8% and 3D was 37.5%; time required with SUVnavi was significantly shorter than with 2D and 3D (P < 0.001 and P < 0.001, respectively). The time reduction and lesion number had a positive correlation (P < 0.001 and P < 0.001, respectively). SUVmax agreed with precise SUVmax in all lesions measured with SUVnavi and 3D but in only 466 of 661 lesions (70.5%) measured with 2D.
CONCLUSION: SUVnavi may be useful for rapid [18F]-fluorodeoxyglucose positron emission tomography/computed tomography ([18F]-FDG PET/CT) image interpretation without reducing the accuracy of SUVmax measurement.

Entities:  

Keywords:  FDG PET; Image interpretation; SUV measurement; Standardized uptake value

Mesh:

Substances:

Year:  2017        PMID: 28497349     DOI: 10.1007/s11604-017-0645-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  25 in total

1.  High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma.

Authors:  Dai Chihara; Yasuhiro Oki; Hiroshi Onoda; Hirofumi Taji; Kazuhito Yamamoto; Tsuneo Tamaki; Yasuo Morishima
Journal:  Int J Hematol       Date:  2011-04-06       Impact factor: 2.490

2.  SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.

Authors:  René-Olivier Casasnovas; Michel Meignan; Alina Berriolo-Riedinger; Stéphane Bardet; Anne Julian; Catherine Thieblemont; Pierre Vera; Serge Bologna; Josette Brière; Jean-Philippe Jais; Corinne Haioun; Bertrand Coiffier; Franck Morschhauser
Journal:  Blood       Date:  2011-04-25       Impact factor: 22.113

3.  Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy.

Authors:  Yohei Imamura; Koichi Azuma; Seiji Kurata; Satoshi Hattori; Tetsuro Sasada; Takashi Kinoshita; Masaki Okamoto; Tomotaka Kawayama; Hayato Kaida; Masatoshi Ishibashi; Hisamichi Aizawa
Journal:  Lung Cancer       Date:  2010-04-28       Impact factor: 5.705

4.  Interim 18F-FDG PET SUVmax reduction is superior to visual analysis in predicting outcome early in Hodgkin lymphoma patients.

Authors:  Cédric Rossi; Salim Kanoun; Alina Berriolo-Riedinger; Inna Dygai-Cochet; Olivier Humbert; Caroline Legouge; Marie Lorraine Chrétien; Jean-Noel Bastie; François Brunotte; René-Olivier Casasnovas
Journal:  J Nucl Med       Date:  2014-02-24       Impact factor: 10.057

5.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

Authors:  H Young; R Baum; U Cremerius; K Herholz; O Hoekstra; A A Lammertsma; J Pruim; P Price
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

6.  Positron emission tomography for predicting recurrence in stage I lung adenocarcinoma: standardized uptake value corrected by mean liver standardized uptake value.

Authors:  Satoshi Shiono; Masami Abiko; Toshimasa Okazaki; Masato Chiba; Hiroshi Yabuki; Toru Sato
Journal:  Eur J Cardiothorac Surg       Date:  2011-04-19       Impact factor: 4.191

7.  Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.

Authors:  Keishi Makino; Toshinori Hirai; Hideo Nakamura; Ryuji Murakami; Mika Kitajima; Yoshinori Shigematsu; Rumi Nakashima; Shinya Shiraishi; Hiroyuki Uetani; Koya Iwashita; Masuma Akter; Yasuyuki Yamashita; Jun-ichi Kuratsu
Journal:  Ann Nucl Med       Date:  2011-03-16       Impact factor: 2.668

Review 8.  Measuring response with FDG-PET: methodological aspects.

Authors:  Martin Allen-Auerbach; Wolfgang A Weber
Journal:  Oncologist       Date:  2009-04-08

9.  FDG positron emission tomography/computed tomography scan may identify mantle cell lymphoma patients with unusually favorable outcome.

Authors:  Maroun Karam; Ashar Ata; Kevin Irish; Paul J Feustel; Felix M Mottaghy; Sigrid G Stroobants; Gregor E Verhoef; Surya Chundru; Vonda Douglas-Nikitin; Ching-yee Oliver Wong; Lieselot M Brepoels
Journal:  Nucl Med Commun       Date:  2009-10       Impact factor: 1.690

10.  ¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.

Authors:  Chang-Bae Kong; Byung Hyun Byun; Ilhan Lim; Chang Woon Choi; Sang Moo Lim; Won Seok Song; Wan Hyeong Cho; Dae-Geun Jeon; Jae-Soo Koh; Ji Young Yoo; Soo-Yong Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-01-30       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.